vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and FVCBankcorp, Inc. (FVCB). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $16.9M, roughly 1.1× FVCBankcorp, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 34.7%). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $-2.8M). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs 36.8%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
APYX vs FVCB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $16.9M |
| Net Profit | $-1.3M | — |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 43.7% |
| Net Margin | -6.8% | — |
| Revenue YoY | 34.7% | 4377.5% |
| Net Profit YoY | 71.9% | — |
| EPS (diluted) | — | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $16.9M | ||
| Q3 25 | $12.9M | $416.0K | ||
| Q2 25 | $11.4M | $15.8M | ||
| Q1 25 | $9.4M | $382.0K | ||
| Q4 24 | $14.2M | $378.0K | ||
| Q3 24 | $11.5M | $412.0K | ||
| Q2 24 | $12.1M | $415.0K | ||
| Q1 24 | $10.2M | $359.0K |
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $-2.0M | $5.6M | ||
| Q2 25 | $-3.8M | $5.7M | ||
| Q1 25 | $-4.2M | $5.2M | ||
| Q4 24 | $-4.6M | — | ||
| Q3 24 | $-4.7M | $4.7M | ||
| Q2 24 | $-6.6M | $4.2M | ||
| Q1 24 | $-7.6M | $1.3M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 43.7% | ||
| Q3 25 | -6.5% | — | ||
| Q2 25 | -22.6% | 45.9% | ||
| Q1 25 | -32.4% | — | ||
| Q4 24 | -21.4% | — | ||
| Q3 24 | -31.6% | — | ||
| Q2 24 | -45.7% | — | ||
| Q1 24 | -64.6% | — |
| Q4 25 | -6.8% | — | ||
| Q3 25 | -15.4% | 1341.1% | ||
| Q2 25 | -33.2% | 36.0% | ||
| Q1 25 | -44.0% | 1352.1% | ||
| Q4 24 | -32.5% | — | ||
| Q3 24 | -40.9% | 1133.3% | ||
| Q2 24 | -54.0% | 1001.2% | ||
| Q1 24 | -74.0% | 373.3% |
| Q4 25 | — | $0.31 | ||
| Q3 25 | — | $0.31 | ||
| Q2 25 | — | $0.31 | ||
| Q1 25 | — | $0.28 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | — | $0.25 | ||
| Q2 24 | $-0.19 | $0.23 | ||
| Q1 24 | $-0.22 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | — |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $253.6M |
| Total Assets | $66.8M | $2.3B |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | — | ||
| Q3 25 | $25.1M | — | ||
| Q2 25 | $29.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $32.7M | — | ||
| Q1 24 | $37.3M | — |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $253.6M | ||
| Q3 25 | $5.8M | $249.8M | ||
| Q2 25 | $7.3M | $243.2M | ||
| Q1 25 | $10.5M | $242.3M | ||
| Q4 24 | $14.2M | $235.4M | ||
| Q3 24 | $11.0M | $230.8M | ||
| Q2 24 | $14.7M | $226.5M | ||
| Q1 24 | $20.3M | $220.7M |
| Q4 25 | $66.8M | $2.3B | ||
| Q3 25 | $57.4M | $2.3B | ||
| Q2 25 | $58.2M | $2.2B | ||
| Q1 25 | $60.2M | $2.2B | ||
| Q4 24 | $64.8M | $2.2B | ||
| Q3 24 | $60.7M | $2.3B | ||
| Q2 24 | $65.4M | $2.3B | ||
| Q1 24 | $70.7M | $2.2B |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $23.9M |
| Free Cash FlowOCF − Capex | $-2.8M | $23.8M |
| FCF MarginFCF / Revenue | -14.6% | 140.7% |
| Capex IntensityCapex / Revenue | 1.4% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $40.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $23.9M | ||
| Q3 25 | $-3.5M | $7.6M | ||
| Q2 25 | $-1.2M | $3.3M | ||
| Q1 25 | $-702.0K | $5.4M | ||
| Q4 24 | $-2.9M | $18.2M | ||
| Q3 24 | $-4.4M | $4.7M | ||
| Q2 24 | $-4.3M | $1.6M | ||
| Q1 24 | $-6.3M | $7.2M |
| Q4 25 | $-2.8M | $23.8M | ||
| Q3 25 | $-4.1M | $7.6M | ||
| Q2 25 | $-1.5M | $3.3M | ||
| Q1 25 | $-757.0K | $5.4M | ||
| Q4 24 | $-3.2M | $18.1M | ||
| Q3 24 | $-4.6M | $4.6M | ||
| Q2 24 | $-4.6M | $1.5M | ||
| Q1 24 | $-6.4M | $7.1M |
| Q4 25 | -14.6% | 140.7% | ||
| Q3 25 | -31.5% | 1818.0% | ||
| Q2 25 | -13.2% | 20.8% | ||
| Q1 25 | -8.0% | 1413.6% | ||
| Q4 24 | -22.4% | 4786.0% | ||
| Q3 24 | -40.0% | 1121.8% | ||
| Q2 24 | -38.0% | 361.2% | ||
| Q1 24 | -62.2% | 1988.3% |
| Q4 25 | 1.4% | 0.3% | ||
| Q3 25 | 4.0% | 0.2% | ||
| Q2 25 | 2.3% | 0.1% | ||
| Q1 25 | 0.6% | 4.2% | ||
| Q4 24 | 1.7% | 37.3% | ||
| Q3 24 | 1.3% | 14.1% | ||
| Q2 24 | 2.4% | 12.8% | ||
| Q1 24 | 0.3% | 3.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 5.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
